{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T10:09:15Z","timestamp":1774865355221,"version":"3.50.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,1,29]],"date-time":"2013-01-29T00:00:00Z","timestamp":1359417600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Heart Vessels"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1007\/s00380-012-0321-y","type":"journal-article","created":{"date-parts":[[2013,1,28]],"date-time":"2013-01-28T08:32:09Z","timestamp":1359361929000},"page":"7-14","source":"Crossref","is-referenced-by-count":6,"title":["Accelerated decline in renal function after acute myocardial infarction in patients with high low-density lipoprotein-cholesterol to high-density lipoprotein-cholesterol ratio"],"prefix":"10.1007","volume":"29","author":[{"given":"Satoshi","family":"Okumura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaki","family":"Sakakibara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Hayashida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Jinno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihito","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Okada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mutsuharu","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toyoaki","family":"Murohara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,1,29]]},"reference":[{"key":"321_CR1","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1001\/jama.297.5.499","volume":"297","author":"SJ Nicholls","year":"2007","unstructured":"Nicholls SJ, Tuzcu EM, Sipahi I, Grasso AW, Schoenhagen P, Hu T, Wolski K, Crowe T, Desai MY, Hazen SL, Kapadia SR, Nissen SE (2007) Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis. JAMA 297:499\u2013508","journal-title":"JAMA"},{"key":"321_CR2","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1253\/circj.CJ-10-0258","volume":"75","author":"I Matsumoto","year":"2011","unstructured":"Matsumoto I, Miyake Y, Mizukawa M, Takagi Y (2011) Impact of low-density lipoprotein cholesterol\/high-density lipoprotein cholesterol ratio on long-term outcome in patients undergoing percutaneous coronary intervention. Circ J 75:905\u2013910","journal-title":"Circ J"},{"key":"321_CR3","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S0272-6386(12)70186-5","volume":"22","author":"H Mulec","year":"1993","unstructured":"Mulec H, Johnsen SA, Wiklund O, Bj\u00f6rck S (1993) Cholesterol: a renal risk factor in diabetic nephropathy? Am J Kidney Dis 22:196\u2013201","journal-title":"Am J Kidney Dis"},{"key":"321_CR4","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1001\/archinte.158.9.998","volume":"158","author":"M Ravid","year":"1998","unstructured":"Ravid M, Brosh D, Ravid-Safran D, Levy Z, Rachmani R (1998) Main risk factors for nephropathy in type 2 diabetes mellitus are plasma cholesterol levels, mean blood pressure, and hyperglycemia. Arch Intern Med 158:998\u20131004","journal-title":"Arch Intern Med"},{"key":"321_CR5","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1093\/ndt\/12.9.1908","volume":"12","author":"O Samuelsson","year":"1997","unstructured":"Samuelsson O, Mulec H, Knight-Gibson C, Attman PO, Kron B, Larsson R, Weiss L, Wedel H, Alaupovic P (1997) Lipoprotein abnormalities are associated with increased rate of progression of human chronic renal insufficiency. Nephrol Dial Transplant 12:1908\u20131915","journal-title":"Nephrol Dial Transplant"},{"key":"321_CR6","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1046\/j.1523-1755.2000.00165.x","volume":"58","author":"P Muntner","year":"2005","unstructured":"Muntner P, Coresh J, Smith JC, Eckfeldt J, Klag MJ (2005) Plasma lipids and risk of developing renal dysfunction: the atherosclerosis risk in communities study. Kidney Int 58:293\u2013301","journal-title":"Kidney Int"},{"key":"321_CR7","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1161\/01.HYP.26.4.670","volume":"26","author":"M M\u00e4ntt\u00e4ri","year":"1995","unstructured":"M\u00e4ntt\u00e4ri M, Tiula E, Alikoski T, Manninen V (1995) Effects of hypertension and dyslipidemia on the decline in renal function. Hypertension 26:670\u2013675","journal-title":"Hypertension"},{"issue":"5","key":"321_CR8","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/S0195-668X(02)00526-2","volume":"24","author":"HL Hillege","year":"2003","unstructured":"Hillege HL, van Gilst WH, van Veldhuisen DJ, Navis G, Grobbee DE, de Graeff PA, de Zeeuw D (2003) Accelerated decline and prognostic impact of renal function after myocardial infarction and the benefits of ACE inhibition: the CATS randomized trial. Eur Heart J 24(5):412\u2013420","journal-title":"Eur Heart J"},{"key":"321_CR9","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1001\/jama.285.13.1711","volume":"285","author":"GG Schwartz","year":"2001","unstructured":"Schwartz GG, Olsson AG, Ezekowitz MD, Ganz P, Oliver MF, Waters D, Zeiher A, Chaitman BR, Leslie S, Stern T, Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study Investigators (2001) Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial. JAMA 285:1711\u20131718","journal-title":"JAMA"},{"key":"321_CR10","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1056\/NEJMoa040583","volume":"350","author":"CP Cannon","year":"2004","unstructured":"Cannon CP, Braunwald E, McCabe CH, Rader DJ, Rouleau JL, Belder R, Joyal SV, Hill KA, Pfeffer MA, Skene AM, Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 Investigators (2004) Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med 350:1495\u20131504","journal-title":"N Engl J Med"},{"key":"321_CR11","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s00380-005-0901-1","volume":"21","author":"M Kanada\u015fi","year":"2006","unstructured":"Kanada\u015fi M, \u00c7ayli M, Demirta\u015f M, \u0130nal T, Demor M, Ko\u00e7 M, Avkaro\u011fullari M, D\u00f6nmez Y, Usal A, Alhan CC, \u015ean M (2006) The effect of early statin treatment on inflammation and cardiac events in acute coronary syndrome with low-density lipoprotein cholesterol. Heart Vessels 21:291\u2013297","journal-title":"Heart Vessels"},{"key":"321_CR12","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.amjcard.2005.04.029","volume":"96","author":"GC Fonarow","year":"2005","unstructured":"Fonarow GC, Wright RS, Spencer FA, Fredrick PD, Dong W, Every N, French WJ, National Registry of Myocardial Infarction 4 Investigators (2005) Effect of statin use within the first 24 hours of admission for acute myocardial infarction on early morbidity and mortality. Am J Cardiol 96:611\u2013616","journal-title":"Am J Cardiol"},{"key":"321_CR13","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1161\/CIRCULATIONAHA.104.517565","volume":"112","author":"M Tonelli","year":"2005","unstructured":"Tonelli M, Isles C, Craven T, Tonkin A, Pfeffer MA, Shepherd J, Sacks FM, Furberg C, Cobbe SM, Simes J, West M, Packard C, Curhan GC (2005) Effect of pravastatin on rate of kidney function loss in people with or at risk for coronary disease. Circulation 112:171\u2013178","journal-title":"Circulation"},{"key":"321_CR14","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1053\/j.ajkd.2008.12.034","volume":"53","author":"S Matsuo","year":"2009","unstructured":"Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, Yamagata K, Tomino Y, Yokoyama H, Hishida A, Collaborators developing the Japanese equation for estimated GFR (2009) Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 53:982\u2013992","journal-title":"Am J Kidney Dis"},{"key":"321_CR15","unstructured":"Nakamura H, Mizuno K, MEGA Study Group (2008) Lowered ratio of low-density lipoprotein cholesterol to high-density lipoprotein cholesterol with lipid-lowering therapy associated with reduction of cardiovascular events in primary prevention: MEGA Study post hoc analysis. Circulation 118:S_1174"},{"issue":"7","key":"321_CR16","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1001\/jama.298.7.776","volume":"298","author":"E Ingelsson","year":"2007","unstructured":"Ingelsson E, Schaefer EJ, Contois JH, McNamara JR, Sullivan L, Keyes MJ, Pencina MJ, Schoonmaker C, Wilson PW, D\u2019Agostino RB, Vasan RS (2007) Clinical utility of different lipid measures for prediction of coronary heart disease in men and women. JAMA 298(7):776\u2013785","journal-title":"JAMA"},{"issue":"5","key":"321_CR17","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.mcna.2011.06.003","volume":"95","author":"R Franssen","year":"2011","unstructured":"Franssen R, Monajemi H, Stoes ES, Kastelein JJ (2011) Obesity and dyslipidemia. Med Clin N Am 95(5):893\u2013902","journal-title":"Med Clin N Am"},{"key":"321_CR18","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.amjcard.2005.11.031","volume":"97","author":"T Sakamoto","year":"2006","unstructured":"Sakamoto T, Kojima S, Ogawa H, Shimomura H, Kimura K, Ogata Y, Sakaino N, Kitagawa A, Multicenter Study for Aggressive Lipid-Lowering Strategy by HMG-CoA Reductase Inhibitors in Patients With Acute Myocardial Infarction Investigators (2006) Effects of early statin treatment on symptomatic heart failure and ischemic events after acute myocardial infarction in Japanese. Am J Cardiol 97:1165\u20131171","journal-title":"Am J Cardiol"},{"key":"321_CR19","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1185\/030079902125000787","volume":"18","author":"VG Athyros","year":"2002","unstructured":"Athyros VG, Papageorgiou AA, Mercouris BR, Athyrou VV, Symeonidis AN, Basayannis EO, Demitriadis DS, Kontopoulos AG (2002) Treatment with atorvastatin to the National Cholesterol Educational Program goal versus \u2018usual\u2019 care in secondary coronary heart disease prevention. The GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) Study. Curr Med Res Opin 18:220\u2013228","journal-title":"Curr Med Res Opin"},{"key":"321_CR20","doi-asserted-by":"crossref","first-page":"F981","DOI":"10.1152\/ajprenal.00229.2005","volume":"291","author":"MJ Burne-Taney","year":"2006","unstructured":"Burne-Taney MJ, Liu M, Ascon D, Molls RR, Racusen L, Rabb H (2006) Transfer of lymphocytes from mice with renal ischemia can induce albuminuria in na\u00efve mice: a possible mechanism linking early injury and progressive renal disease? Am J Physiol Renal Physiol 291:F981\u2013F986","journal-title":"Am J Physiol Renal Physiol"},{"key":"321_CR21","doi-asserted-by":"crossref","first-page":"F688","DOI":"10.1152\/ajprenal.00452.2006","volume":"293","author":"M H\u00f6rbelt","year":"2007","unstructured":"H\u00f6rbelt M, Lee SY, Mang HE, Knipe NL, Sado Y, Kribben A, Sutton TA (2007) Acute and chronic microvascular alterations in a mouse model of ischemic acute kidney injury. Am J Physiol Renal Physiol 293:F688\u2013F695","journal-title":"Am J Physiol Renal Physiol"},{"key":"321_CR22","doi-asserted-by":"crossref","first-page":"F1334","DOI":"10.1152\/ajprenal.00431.2011","volume":"301","author":"RA Zager","year":"2011","unstructured":"Zager RA, Johnson AC, Becker K (2011) Acute unilateral ischemic injury induces progressive renal inflammation, lipid accumulation, histone modification, and \u201cend-stage\u201d kidney disease. Am J Physiol Renal Physiol 301:F1334\u2013F1345","journal-title":"Am J Physiol Renal Physiol"},{"key":"321_CR23","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1038\/ki.2009.332","volume":"76","author":"RL Amdur","year":"2009","unstructured":"Amdur RL, Chawla LS, Amodeo S, Kimmel PL, Palant CE (2009) Outcomes following diagnosis of acute renal failure in U.S. veterans: focus on acute tubular necrosis. Kidney Int 76:1089\u20131097","journal-title":"Kidney Int"},{"key":"321_CR24","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1001\/jama.2009.1322","volume":"302","author":"R Wald","year":"2009","unstructured":"Wald R, Quinn RR, Luo J, Li P, Scales DC, Mamdani MM, Ray JG, University of Toronto Acute Kidney Injury Research Group (2009) Chronic dialysis and death among survivors of acute kidney injury requiring dialysis. JAMA 302:1179\u20131185","journal-title":"JAMA"},{"key":"321_CR25","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1038\/ki.2009.289","volume":"76","author":"LJ Lo","year":"2009","unstructured":"Lo LJ, Go AS, Chertow GM, McCulloch CE, Fan D, Ordo\u00f1ez JD, Hsu CY (2009) Dialysis-requiring acute renal failure increases the risk of progressive chronic kidney disease. Kidney Int 76:893\u2013899","journal-title":"Kidney Int"},{"key":"321_CR26","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1681\/ASN.2007080837","volume":"20","author":"A Ishani","year":"2009","unstructured":"Ishani A, Xue JL, Himmelfarb J, Eggers PW, Kimmel PL, Molitoris BA, Collins AJ (2009) Acute kidney injury increases risk of ESRD among elderly. J Am Soc Nephrol 20:223\u2013228","journal-title":"J Am Soc Nephrol"},{"key":"321_CR27","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1136\/hrt.2010.218677","volume":"97","author":"J Wi","year":"2011","unstructured":"Wi J, Ko YG, Kim JS, Kim BK, Choi D, Ha JW, Hong MK, Jang Y (2011) Impact of contrast-induced acute kidney injury with transient or persistent renal dysfunction on long-term outcomes of patients with acute myocardial infarction undergoing percutaneous coronary intervention. Heart 97:1753\u20131757","journal-title":"Heart"},{"key":"321_CR28","doi-asserted-by":"crossref","first-page":"8","DOI":"10.2174\/1874192400701010008","volume":"1","author":"VG Athyros","year":"2007","unstructured":"Athyros VG, Kakafika AI, Papageorgiou AA, Pagourelias ED, Savvatianos SD, Elisaf M, Karagiannis A, Tziomalos K, Mikhailidis DP (2007) Statin-induced increase in HDL-C and renal function in coronary heart disease patients. Open Cardiovasc Med J 1:8\u201314","journal-title":"Open Cardiovasc Med J"},{"key":"321_CR29","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0022-2275(20)39898-9","volume":"36","author":"CJ Fielding","year":"1995","unstructured":"Fielding CJ, Fielding PE (1995) Molecular physiology of reverse cholesterol transport. J Lipid Res 36:211\u2013228","journal-title":"J Lipid Res"},{"key":"321_CR30","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1161\/01.ATV.0000164805.73558.80","volume":"25","author":"F Robbesyn","year":"2005","unstructured":"Robbesyn F, Aug\u00e9 N, Vindis C, Cantero AV, Barbaras R, Negre-Salvayre A, Salvayre R (2005) High-density lipoproteins prevent the oxidized low-density lipoprotein-induced epidermal [corrected] growth factor receptor activation and subsequent matrix metalloproteinase-2 upregulation. Arterioscler Thromb Vasc Biol 25:1206\u20131212","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"321_CR31","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/S0140-6736(82)91513-6","volume":"2","author":"JF Moorhead","year":"1982","unstructured":"Moorhead JF, Chan MK, El-Nahas M, Varghese Z (1982) Lipid nephrotoxicity in chronic progressive glomerular and tubulo-interstitial disease. Lancet 2:1309\u20131311","journal-title":"Lancet"},{"key":"321_CR32","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1159\/000075925","volume":"24","author":"CK Abrass","year":"2004","unstructured":"Abrass CK (2004) Cellular lipid metabolism and the role of lipids in progressive renal disease. Am J Nephrol 24:46\u201353","journal-title":"Am J Nephrol"},{"key":"321_CR33","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1016\/j.jacc.2011.08.030","volume":"58","author":"PJ Patel","year":"2011","unstructured":"Patel PJ, Khera AV, Jafri K, Wilensky RL, Rader DJ (2011) The anti-oxidative capacity of high-density lipoprotein is reduced in acute coronary syndrome but not in stable coronary artery disease. J Am Coll Cardiol 58:2068\u20132075","journal-title":"J Am Coll Cardiol"},{"key":"321_CR34","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1111\/j.1523-1755.2005.00457.x","volume":"68","author":"TM Lee","year":"2005","unstructured":"Lee TM, Lin MS, Tsai CH, Chang NC (2005) Add-on and withdrawal effect of pravastatin on proteinuria in hypertensive patients treated with AT receptor blockers. Kidney Int 68:779\u2013787","journal-title":"Kidney Int"},{"key":"321_CR35","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1067\/mcp.2000.105330","volume":"67","author":"M Buemi","year":"2000","unstructured":"Buemi M, Allegra A, Corica F, Aloisi C, Giacobbe M, Pettinato G, Corsonello A, Senatore M, Frisina N (2000) Effect of fluvastatin on proteinuria in patients with immunoglobulin A nephropathy. Clin Pharmacol Ther 67:427\u2013431","journal-title":"Clin Pharmacol Ther"},{"key":"321_CR36","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1253\/circj.CJ-10-0110","volume":"74","author":"Q Zhou","year":"2010","unstructured":"Zhou Q, Liao JK (2010) Pleiotropic effects of statins: basic research and clinical perspectives. Circ J 74:818\u2013826","journal-title":"Circ J"},{"key":"321_CR37","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1007\/s00380-010-0097-x","volume":"26","author":"C Skogastierna","year":"2011","unstructured":"Skogastierna C, Luksha L, Kublickiene K, Eliasson E, Rane A, Ekstr\u00f6m L (2011) Beneficial vasoactive endothelial effects of fluvastatin: focus on prostacyclin and nitric oxide. Heart Vessels 26:628\u2013636","journal-title":"Heart Vessels"},{"key":"321_CR38","author":"M Lunder","year":"2012","unstructured":"Lunder M, Ziberna L, Jani\u0107 M, Jerin A, Skitek M, Sabovi\u010d M, Dreven\u0161ek G (2012) Low-dose atorvastatin, losartan, and particularly their combination, provide cardiovascular protection in isolated rat heart and aorta. Heart Vessels. doi: 10.1007\/s00380-012-0259-0","journal-title":"Heart Vessels"},{"key":"321_CR39","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/ndt\/gfq662","volume":"26","author":"K Amann","year":"2011","unstructured":"Amann K, Benz K (2011) Statins: beyond lipids in CKD. Nephrol Dial Transplant 26:407\u2013410","journal-title":"Nephrol Dial Transplant"},{"key":"321_CR40","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/ki.2008.231","volume":"74","author":"LF Fried","year":"2008","unstructured":"Fried LF (2008) Effects of HMG-CoA reductase inhibitors (statins) on progression of kidney disease. Kidney Int 74:571\u2013576","journal-title":"Kidney Int"},{"key":"321_CR41","doi-asserted-by":"crossref","first-page":"S148","DOI":"10.1681\/ASN.2005121341","volume":"17","author":"G D\u2019Amico","year":"2006","unstructured":"D\u2019Amico G (2006) Statins and renal disease: from primary prevention to renal replacement therapy. J Am Soc Nephrol 17:S148\u2013S152","journal-title":"J Am Soc Nephrol"}],"container-title":["Heart and Vessels"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00380-012-0321-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00380-012-0321-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00380-012-0321-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,6]],"date-time":"2022-02-06T21:46:25Z","timestamp":1644183985000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00380-012-0321-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,29]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["321"],"URL":"https:\/\/doi.org\/10.1007\/s00380-012-0321-y","relation":{},"ISSN":["0910-8327","1615-2573"],"issn-type":[{"value":"0910-8327","type":"print"},{"value":"1615-2573","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,29]]}}}